Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 476 | 462 | 755 | 503 | 485 |
| Cost of Goods | 1,256 | 32 | 140 | 7 | 13 |
| Gross Profit | -780 | 430 | 615 | 496 | 472 |
| Operating Expenses | 13,685 | 15,102 | 15,146 | 14,313 | 12,857 |
| Operating Income | -14,209 | -14,640 | -14,391 | -13,810 | -12,372 |
| Other Income | 608 | 591 | 583 | 510 | 392 |
| Pre-tax Income | -13,601 | -14,049 | -13,808 | -13,300 | -11,980 |
| Net Income Continuous | -13,601 | -14,049 | -13,808 | -13,300 | -11,980 |
| Net Income | $-13,601 | $-14,049 | $-13,808 | $-13,300 | $-11,980 |
| EPS Basic Total Ops | -0.28 | -0.29 | -0.29 | -0.28 | -0.19 |
| EPS Basic Continuous Ops | -0.28 | -0.29 | -0.29 | -0.28 | -0.19 |
| EPS Diluted Total Ops | -0.28 | -0.29 | -0.29 | -0.28 | -0.19 |
| EPS Diluted Continuous Ops | -0.28 | -0.29 | -0.29 | -0.28 | -0.19 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.29 | -0.29 | -0.28 | -0.29 |
| EBITDA(a) | $-14,261 | $-14,697 | $-14,431 | $-13,876 | $-12,348 |